SynthesisAnnals of oncology : official journal of the European Society for Medical Oncology2013

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.

E M Olson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.